Kineret (Amgen Inc) en es it fr

Kineret (Amgen Inc) Brand names, Kineret (Amgen Inc) Analogs

Kineret (Amgen Inc) Brand Names Mixture

  • No information avaliable

Kineret (Amgen Inc) Chemical_Formula

C759H1186N208O232S10

Kineret (Amgen Inc) RX_link

http://www.rxlist.com/cgi/generic/anakinra.htm

Kineret (Amgen Inc) fda sheet

Kineret (Amgen Inc) msds (material safety sheet)

Kineret (Amgen Inc) Synthesis Reference

No information avaliable

Kineret (Amgen Inc) Molecular Weight

17257.6

Kineret (Amgen Inc) Melting Point

No information avaliable

Kineret (Amgen Inc) H2O Solubility

No information avaliable

Kineret (Amgen Inc) State

Liquid

Kineret (Amgen Inc) LogP

-0.412

Kineret (Amgen Inc) Dosage Forms

Solution

Kineret (Amgen Inc) Indication

For treatment of adult rheumatoid arthritis

Kineret (Amgen Inc) Pharmacology

Used to treat rheumatoid arthritis, Kineret blocks the biologic activity of IL-1 by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs.1 IL-1 production is induced in response to inflammatory stimuli and mediates various physiologic responses including inflammatory and immunological responses. Patients with rheumatoid arthritis have elevated levels of IL-1. The levels of the naturally occurring IL-1Ra in synovium and synovial fluid from rheumatoid arthritis (RA) patients are not sufficient to compete with the elevated amount of locally produced IL-1. Increasing the levels of IL-1Ra by artificial means reduces the negative effects (cartilage degradation, bone resorption) of IL-1.

Kineret (Amgen Inc) Absorption

No information avaliable

Kineret (Amgen Inc) side effects and Toxicity

No information avaliable

Kineret (Amgen Inc) Patient Information

BIOD00060.html

Kineret (Amgen Inc) Organisms Affected

Humans and other mammals